The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry

Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre

(2014) Chloe B. Wilcox et al.   BJU INTERNATIONAL

Variation in Use of Active Surveillance among Men Undergoing Expectant Treatment for Early Stage Prostate Cancer

(2014) Christopher P. Filson et al.   JOURNAL OF UROLOGY

‘What is this active surveillance thing?’ Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option

(2014) Clare O'Callaghan et al.   PSYCHO-ONCOLOGY

Physician Variation in Management of Low-Risk Prostate Cancer

(2014) Karen E. Hoffman et al.   JAMA Internal Medicine

Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy

(2013) Kingsley Ekwueme et al.   BJU INTERNATIONAL

Long-term Prostate-specific Antigen Velocity in Improved Classification of Prostate Cancer Risk and Mortality

(2013) David D. Ørsted et al.   EUROPEAN UROLOGY

Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011

(2013) Sue M Evans et al.   MEDICAL JOURNAL OF AUSTRALIA

The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer

(2012) Sue M. Evans et al.   BJU INTERNATIONAL

International Variation in Prostate Cancer Incidence and Mortality Rates

(2012) Melissa M. Center et al.   EUROPEAN UROLOGY

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

(2012) Marc A. Dall’Era et al.   EUROPEAN UROLOGY

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

(2012) Meelan Bul et al.   EUROPEAN UROLOGY

Radical Prostatectomy versus Observation for Localized Prostate Cancer

(2012) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

(2011) William J. Catalona et al.   JOURNAL OF UROLOGY

‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging

(2009) Nathan Lawrentschuk et al.   BJU INTERNATIONAL

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

(2009) Monique J. Roobol et al.   EUROPEAN UROLOGY

Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer

(2009) Laurence Klotz et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly

(2008) Roderick C.N. van den Bergh et al.   EUROPEAN UROLOGY